Whatever...IPCI's CEO has a proven track record since inception as being extremely frugal when it comes to managing IPCI's capital structure and they're generating just over +$1M in revenues per quarter on their 2 approved FocalinXR strengths...so welcome to ihub and best advice any long term IPCI s/h can offer is that the sell button's just a click away if you're skeered of dilution lol